Table of Contents

2019-2024 Global Neurological Biomarkers Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurological Biomarkers Consumption 2014-2024
2.1.2 Neurological Biomarkers Consumption CAGR by Region
2.2 Neurological Biomarkers Segment by Type
2.2.1 Proteomics
2.2.2 Genomics
2.2.3 Imaging
2.2.4 Bioinformatics
2.2.5 Others
2.3 Neurological Biomarkers Consumption by Type
2.3.1 Global Neurological Biomarkers Consumption Market Share by Type (2014-2019)
2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2014-2019)
2.3.3 Global Neurological Biomarkers Sale Price by Type (2014-2019)
2.4 Neurological Biomarkers Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Neurological Biomarkers Consumption by Application
2.5.1 Global Neurological Biomarkers Consumption Market Share by Application (2014-2019)
2.5.2 Global Neurological Biomarkers Value and Market Share by Application (2014-2019)
2.5.3 Global Neurological Biomarkers Sale Price by Application (2014-2019)

3 Global Neurological Biomarkers by Players
3.1 Global Neurological Biomarkers Sales Market Share by Players
3.1.1 Global Neurological Biomarkers Sales by Players (2017-2019)
3.1.2 Global Neurological Biomarkers Sales Market Share by Players (2017-2019)
3.2 Global Neurological Biomarkers Revenue Market Share by Players
3.2.1 Global Neurological Biomarkers Revenue by Players (2017-2019)
3.2.2 Global Neurological Biomarkers Revenue Market Share by Players (2017-2019)
3.3 Global Neurological Biomarkers Sale Price by Players
3.4 Global Neurological Biomarkers Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Neurological Biomarkers Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Neurological Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Neurological Biomarkers by Regions
4.1 Neurological Biomarkers by Regions
4.1.1 Global Neurological Biomarkers Consumption by Regions
4.1.2 Global Neurological Biomarkers Value by Regions
4.2 Americas Neurological Biomarkers Consumption Growth
4.3 APAC Neurological Biomarkers Consumption Growth
4.4 Europe Neurological Biomarkers Consumption Growth
4.5 Middle East & Africa Neurological Biomarkers Consumption Growth

5 Americas
5.1 Americas Neurological Biomarkers Consumption by Countries
5.1.1 Americas Neurological Biomarkers Consumption by Countries (2014-2019)
5.1.2 Americas Neurological Biomarkers Value by Countries (2014-2019)
5.2 Americas Neurological Biomarkers Consumption by Type
5.3 Americas Neurological Biomarkers Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Neurological Biomarkers Consumption by Countries
6.1.1 APAC Neurological Biomarkers Consumption by Countries (2014-2019)
6.1.2 APAC Neurological Biomarkers Value by Countries (2014-2019)
6.2 APAC Neurological Biomarkers Consumption by Type
6.3 APAC Neurological Biomarkers Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Neurological Biomarkers by Countries
7.1.1 Europe Neurological Biomarkers Consumption by Countries (2014-2019)
7.1.2 Europe Neurological Biomarkers Value by Countries (2014-2019)
7.2 Europe Neurological Biomarkers Consumption by Type
7.3 Europe Neurological Biomarkers Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Neurological Biomarkers by Countries
8.1.1 Middle East & Africa Neurological Biomarkers Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Neurological Biomarkers Value by Countries (2014-2019)
8.2 Middle East & Africa Neurological Biomarkers Consumption by Type
8.3 Middle East & Africa Neurological Biomarkers Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neurological Biomarkers Distributors
10.3 Neurological Biomarkers Customer

11 Global Neurological Biomarkers Market Forecast
11.1 Global Neurological Biomarkers Consumption Forecast (2019-2024)
11.2 Global Neurological Biomarkers Forecast by Regions
11.2.1 Global Neurological Biomarkers Forecast by Regions (2019-2024)
11.2.2 Global Neurological Biomarkers Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neurological Biomarkers Forecast by Type
11.8 Global Neurological Biomarkers Forecast by Application

12 Key Players Analysis
12.1 Thermo Fisher Scientific
12.1.1 Company Details
12.1.2 Neurological Biomarkers Product Offered
12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Scientific News
12.2 Merck
12.2.1 Company Details
12.2.2 Neurological Biomarkers Product Offered
12.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Merck News
12.3 Quest Diagnostics
12.3.1 Company Details
12.3.2 Neurological Biomarkers Product Offered
12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Quest Diagnostics News
12.4 Abbott
12.4.1 Company Details
12.4.2 Neurological Biomarkers Product Offered
12.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Abbott News
12.5 Roche
12.5.1 Company Details
12.5.2 Neurological Biomarkers Product Offered
12.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Roche News
12.6 Illumina
12.6.1 Company Details
12.6.2 Neurological Biomarkers Product Offered
12.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Illumina News
12.7 Bio-Rad Laboratories
12.7.1 Company Details
12.7.2 Neurological Biomarkers Product Offered
12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Bio-Rad Laboratories News
12.8 QIAGEN
12.8.1 Company Details
12.8.2 Neurological Biomarkers Product Offered
12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 QIAGEN News
12.9 Myriad RBM
12.9.1 Company Details
12.9.2 Neurological Biomarkers Product Offered
12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Myriad RBM News
12.10 Cisbio Bioassays
12.10.1 Company Details
12.10.2 Neurological Biomarkers Product Offered
12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Cisbio Bioassays News
12.11 Athena Diagnostics
12.12 BGI
12.13 Wuxi APP
12.14 Aepodia
12.15 Proteome Sciences
12.16 Genewiz

13 Research Findings and Conclusion